Abstract PO1-28-07: Neoadjuvant Docetaxel Plus Cisplatin Versus Docetaxel Plus Doxorubicin and Cyclophosphamide in Early-Stage Triple-Negative Breast Cancer (HNBC-001): Results from a Multicenter, Randomized Controlled, Open-Label Phase II Trial
Cancer Research(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要